Literature DB >> 9387925

Target and signal amplification: approaches to increase the sensitivity of in situ hybridization.

P Komminoth1, M Werner.   

Abstract

In situ hybridization (ISH) has proven to be a very important molecular tool in research and diagnosis. However, its applicability can be limited by its restricted detection sensitivity. During the last few years, several strategies have been developed to improve the threshold levels for ISH detection by amplification of either target nucleic acid sequences prior to ISH or the detection signals after hybridization procedures. In this overview, we outline and analyze the principles, applications, and limitations of in situ polymerase chain reaction, in situ self-sustained sequence replication, primed in situ labeling (PRINS), and in situ transcription as examples of target amplification methods, and catalyzed reporter deposition using biotinylated tyramine as an approach to signal amplification in ISH. We also provide a detailed, 1-day protocol for non-radioactive oligonucleotide ISH including signal amplification, which is suitable for diagnostic purposes. Furthermore, future directions of ISH including combined strategies of target and signal amplification as well as automation are discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9387925     DOI: 10.1007/s004180050173

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  9 in total

Review 1.  Strategies for signal amplification in nucleic acid detection.

Authors:  S C Andras; J B Power; E C Cocking; M R Davey
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

2.  CARD In Situ Hybridization: Sights and Signals.

Authors:  Ernst J. M. Speel; Paul Komminoth
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

3.  Double fluorescence in situ hybridization in fresh brain sections.

Authors:  Jin Kwon Jeong; Zhuoxun Chen; Liisa A Tremere; Raphael Pinaud
Journal:  J Vis Exp       Date:  2010-08-14       Impact factor: 1.355

4.  Genotyping of phenotypically defined cells in neoplasia: enhanced immunoFISH via tyramide signal amplification (TSA) segregates immunophenotypically-defined cell populations for gated genotyping.

Authors:  Raymond R Tubbs; Kingshuk Das; James R Cook; James D Pettay; Patrick C Roche; Thomas Grogan
Journal:  J Mol Histol       Date:  2007-01-05       Impact factor: 3.156

5.  Protein Z/protein Z-dependent protease inhibitor system in loco in human gastric cancer.

Authors:  Ewa Sierko; Marek Z Wojtukiewicz; Lech Zimnoch; Piotr Tokajuk; Krystyna Ostrowska-Cichocka; Walter Kisiel
Journal:  Ann Hematol       Date:  2013-10-26       Impact factor: 3.673

6.  A method for combining RNAscope in situ hybridization with immunohistochemistry in thick free-floating brain sections and primary neuronal cultures.

Authors:  Tessa M Grabinski; Andrew Kneynsberg; Fredric P Manfredsson; Nicholas M Kanaan
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

7.  Fluorescence-coded DNA Nanostructure Probe System to Enable Discrimination of Tumor Heterogeneity via a Screening of Dual Intracellular microRNA Signatures in situ.

Authors:  Seung Won Shin; Byoung Sang Lee; Kisuk Yang; Lunjakorn Amornkitbamrung; Min Su Jang; Bo Mi Ku; Seung-Woo Cho; Jung Heon Lee; Hojae Bae; Byung-Keun Oh; Myung-Ju Ahn; Yong Taik Lim; Soong Ho Um
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

8.  Using Single Molecule mRNA Fluorescent in Situ Hybridization (RNA-FISH) to Quantify mRNAs in Individual Murine Oocytes and Embryos.

Authors:  Fang Xie; Kelsey A Timme; Jennifer R Wood
Journal:  Sci Rep       Date:  2018-05-21       Impact factor: 4.379

9.  Fluorochromized tyramide-glucose oxidase as a multiplex fluorescent tyramide signal amplification system for histochemical analysis.

Authors:  Kenta Yamauchi; Shinichiro Okamoto; Yoko Ishida; Kohtarou Konno; Kisara Hoshino; Takahiro Furuta; Megumu Takahashi; Masato Koike; Kaoru Isa; Masahiko Watanabe; Tadashi Isa; Hiroyuki Hioki
Journal:  Sci Rep       Date:  2022-09-12       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.